atazanavir inhibits sars-cov-2 replication and pro-inflammatory cytokine production
atazanavir inhibits sars-cov-2 replication and pro-inflammatory cytokine production
however, limited evidence exists for other clinically approved antiretroviral protease inhibitors, such as atazanavir (atv).